All funds

SEB Läkemedelsfond D

Equity fund

No data to display ...

1 year

Globe

USA

Largest region

No data to display ...

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years

Description

Investment horizon

  • SEB Läkemedelsfond D is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • Price/NAV

    17 Sept 2025

  • Start date
    04 Sept 2025
  • ISIN
    SE0024788749

Risk

  • Unknown

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Annual cost

  • Ongoing costs

    Includes management fees of 1,50 %

  • Platform fee
  • Kickback fee
  • Annual running costs

Other costs

  • Performance-based fee
  • Transaction costs

  • Costs for any currency exchanges are not included.

Allocation

  • Stocks 99%
    Interest 1%

Portfolio

Shows the fund's largest investments.

  • Eli Lilly and Co
    8.6%
  • AstraZeneca PLC
    6.6%
  • Verona Pharma PLC ADR
    5.3%
  • Merck & Co Inc
    5.0%
  • Thermo Fisher Scientific Inc
    4.7%
  • Novo Nordisk AS Class B
    3.8%
  • Boston Scientific Corp
    3.6%
  • Intuitive Surgical Inc
    3.4%
  • Stryker Corp
    3.0%
  • UCB SA
    2.8%